Monster Beverage Corp vs 10X Genomics Inc — how do they compare? Monster Beverage Corp trades at $94.47 (market cap $93.35B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Monster Beverage Corp is far larger — about 17× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Monster Beverage Corp nearer its low. Which is the better fit depends on your goals.
| MNST | TXG | |
|---|---|---|
Market Cap | $93.35B | $5.48B |
Sector | Consumer Staples | Health |
52-Week High | $99.94 | $45.80 |
52-Week Low | $58.75 | $11.34 |
Enterprise Value | $91.65B | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →